Viewing nowLopatan Tablets 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

MFDS item code 201403882 · Approved 2014.08.20 · Insurance code 693201040
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used as an adjunct in patients with hypercholesterolemia and mixed dyslipidemia that are not adequately controlled by diet and exercise. It is particularly useful for patients with familial hypercholesterolemia and dysbetalipoproteinemia. This drug works by lowering total cholesterol and LDL cholesterol levels, helping to slow the progression of atherosclerosis. It is also effective for pediatric patients aged 10 to 17 with familial hypercholesterolemia under specific conditions. Additionally, it is used to reduce the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged patients at high risk for cardiovascular disease. Overall, this drug is extremely useful for improving blood lipid levels and reducing cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 years to 17 years) Ages 10 years to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. The safety and efficacy in children younger than 10 years have not been established.
This drug should not be taken by certain patients. For example, it should not be administered to patients who are allergic to its components, patients with severe liver dysfunction, patients with muscle diseases, and patients with significantly impaired kidney function. Pregnant or breastfeeding women, as well as women of childbearing age who are not using adequate contraception, should also avoid taking this drug. It is important to monitor liver function tests and muscle conditions periodically while using this drug. Precautions should be taken, especially for patients with a history of liver disease or heavy alcohol consumption. If symptoms of myalgia, muscle weakness, or muscle damage occur, immediate medical attention should be sought. This drug may exacerbate muscle diseases, so discontinuation may be necessary if such symptoms occur. Additionally, interactions may arise when taken with other medications, so it is essential to inform healthcare providers of all medications being taken, particularly antivirals, immunosuppressants, antibiotics, and fibrates. This drug can elevate blood glucose levels, so patients at risk for diabetes should pay attention to blood glucose management. Pregnant and breastfeeding women should not take this drug, and women planning to become pregnant should use appropriate contraceptive methods. There is no specific antidote for overdose, so immediate medical care and assessment should be sought. This drug may cause symptoms like dizziness, so caution should be exercised when driving or operating machinery. Lastly, it is important to consult healthcare professionals immediately if any adverse reactions occur while taking this medication.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture, and it is best kept at temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and prevent deterioration.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.